1. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016; 7:290–298. PMID:
27239410.
Article
2. Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle. 2014; 5:253–259. PMID:
25425503.
Article
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412–423. PMID:
20392703.
Article
4. Baker JF, Von Feldt J, Mostoufi-Moab S, et al. Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014; 66:1612–1618. PMID:
24664868.
Article
5. Giles JT, Ling SM, Ferrucci L, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008; 59:807–815. PMID:
18512711.
Article
6. Targowski T. Sarcopaenia and rheumatoid arthritis. Reumatologia. 2017; 55:84–87. PMID:
28539680.
Article
7. Giles JT, Allison M, Blumenthal RS, et al. Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum. 2010; 62:3173–3182. PMID:
20589684.
Article
8. Baker JF, Giles JT, Weber D, et al. Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Rheumatology (Oxford). 2017; 56:981–988. PMID:
28340012.
Article
9. Weber D, Long J, Leonard MB, et al. Development of novel methods to define deficits in appendicular lean mass relative to fat mass. PLoS One. 2016; 11:e0164385. PMID:
27723820.
Article
10. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62:2569–2581. PMID:
20872595.
11. Prevoo ML, van't Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38:44–48. PMID:
7818570.
Article
12. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15:95–101. PMID:
24461239.
Article
13. Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43:69–77. PMID:
24585853.
Article
14. Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis. 1997; 56:326–329. PMID:
9175935.
Article
15. Pajak B, Orzechowska S, Pijet B, et al. Crossroads of cytokine signaling-the chase to stop muscle cachexia. J Physiol Pharmacol. 2008; 59 Suppl 9:251–264.
16. McDermott MM, Ferrucci L, Guralnik JM, et al. Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol. 2007; 50:897–905. PMID:
17719478.
Article
17. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002; 57:M326–M332. PMID:
11983728.
18. Kramer HR, Fontaine KR, Bathon JM, et al. Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum. 2012; 64:2438–2450. PMID:
22391952.
Article